Skip to main content
. 2014 Aug 28;9(8):e105736. doi: 10.1371/journal.pone.0105736

Table 3. Frequency of mutation by molecule in naive and ART pre-treated patients with virological failure.

Patients Category Patients HIV-1 RNA VL (Log/mL) NRTI NNRTIs
ZDV D4T 3TC/FTC ABC DDI TDF NVP EFV ETR RVP
ARV-naïve patients 10-1806 3,7 R R R PR PR PR R R SS N/A
10-1701 4,5 R R R PR PR PR R R PR N/A
10-1866 3,4 PR R R PR PR PR R R PR R
10.1828 4,3 PR R R PR PR PR R R SS R
11.2005 3,7 PR PR R PR PR PR R R PR PR
11.1919 4,8 PR PR R PR PR PR R R PR PR
10.1872 4,4 PR PR R PR PR PR R R PR N/A
ARV pre-exposed patients 12.2095 5,8 R R R R R R R R PR R
10-1779 4,6 R R R R R R R R PR N/A
10-1885 5,5 PR R R PR PR PR R R R N/A
10-1896 4,4 R R R SS R SS R R PR N/A
10-1830 5,4 R R R PR PR PR R R R N/A
10-1796 4,8 R R R R R SS R R SS N/A
10-1754 5,6 R R R SS PR SS R R PR N/A
1759 4,1 R R R SS R SS PR PR R N/A
11.1990 5,5 PR PR R R R PR R R PR PR
10-1836 5 PR PR PR PR PR PR SS PR PR N/A
1991 4,2 PR PR PR PR PR PR PR PR PR N/A
10-1900 3,5 PR PR PR PR PR PR PR PR PR N/A
11-1963 6,4 PR PR PR PR PR PR PR PR PR N/A
10-1876 3,4 PR PR R PR PR PR R R R N/A
2002 4,1 R R R PR SS SS R R R PR

R = Resistant, PR = Possible resistant, SS = sensitive.